rs28371706
Variant summary
Our verdict is Benign. Variant got -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_000106.6(CYP2D6):c.320C>T(p.Thr107Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0105 in 1,609,412 control chromosomes in the GnomAD database, including 2,087 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign,other (★★). Another nucleotide change resulting in the same amino acid substitution has been previously reported as Likely benign in UniProt.
Frequency
Consequence
NM_000106.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -12 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0518 AC: 7830AN: 151262Hom.: 1010 Cov.: 32
GnomAD3 exomes AF: 0.0141 AC: 3431AN: 244170Hom.: 415 AF XY: 0.0109 AC XY: 1450AN XY: 133408
GnomAD4 exome AF: 0.00619 AC: 9031AN: 1458040Hom.: 1068 Cov.: 33 AF XY: 0.00544 AC XY: 3948AN XY: 725406
GnomAD4 genome AF: 0.0519 AC: 7849AN: 151372Hom.: 1019 Cov.: 32 AF XY: 0.0496 AC XY: 3672AN XY: 73974
ClinVar
Submissions by phenotype
not provided Benign:2Other:1
Likely benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
other, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Aug 06, 2018 | - Variant classified as "other reportable" ??? variant is clinically benign (not associated with disease) but is reported when observed (e.g. pseudodeficiency alleles). |
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | Apr 12, 2018 | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at